Data integrity has always been a cornerstone of clinical research. In 2026, it’s receiving renewed attention, driven by increasing trial complexity, expanded use of digital systems, and more consistent scrutiny during inspections.
Recent FDA 483 observations point to a clear shift: regulators are not just evaluating what data is collected, they’re evaluating how it’s captured, controlled, and maintained across systems.
For research sites, this raises the standard for execution.
Where Inspection Focus Is Shifting
1. Incomplete or Inconsistent Source Documentation
Gaps between source data, regulatory records, and submitted data continue to surface.
These issues are often tied to:
- Multiple systems holding different versions
- Delayed documentation after visits
- Manual reconciliation between paper and electronic records
Inspectors expect a single, traceable source of truth.
2. Increased Scrutiny of Electronic Systems
As digital adoption grows, inspectors are evaluating system controls more closely.
Common findings include:
- Unclear user permissions
- Limited audit trail visibility
- Inconsistent documentation of system usage
Sites must demonstrate who accessed what, when, and why.
3. Remote Monitoring Without Defined Controls
Remote access is now standard but expectations have evolved.
Inspection focus includes:
- Overexposure of PHI
- Lack of defined access windows
- Limited visibility into monitor activity
Remote monitoring must be controlled, role-based, and auditable.
4. Version Control Breakdowns
Outdated ICFs, missing signatures, and conflicting document versions remain leading causes of 483 findings.
These issues typically stem from:
- Documents stored across multiple systems
- Manual update processes
- Reliance on email or shared drives
Inspectors expect real-time version control and document status visibility.
5. Weak Data Governance Across Systems
As sites adopt more tools, governance becomes more complex.
Key concerns:
- Data stored in disconnected systems
- Unclear ownership of data quality
- Inconsistent update and correction processes
The expectation is shifting toward structured, system-driven governance.
What This Means for Research Sites
The shift isn’t about adding more compliance tasks. It’s about reducing variability.
Sites that perform well in inspections:
- Capture data close to the point of care
- Maintain centralized, version-controlled documentation
- Define access based on role
- Maintain complete, accessible audit trails
Data integrity is no longer a back-end check, it’s an operational standard.
As expectations evolve, sites that bring structure and consistency to their workflows will be better positioned for inspections and for long-term growth.